JOURNAL OF BIOMEDICAL SCIENCE, published by BMC, is a premier Open Access journal dedicated to the rapid dissemination of research in the fields of biomedical science, encompassing crucial areas such as biochemistry, cell biology, clinical biochemistry, and more. Since its inception in 1993, the journal has established itself as a leading publication, currently boasting a remarkable impact factor and quality as evidenced by its Q1 quartile rankings across multiple categories in 2023. With an impressive track record, including a Scopus ranking in the top percentiles across several disciplines, it serves as a vital resource for researchers, professionals, and students who are keen on advancing their knowledge in biomedicine. The journal operates under a fully Open Access model, ensuring that all published articles are freely available to the global research community, thus contributing to the broader dissemination and accessibility of scientific knowledge. Based in the United Kingdom, JOURNAL OF BIOMEDICAL SCIENCE is committed to fostering innovation and collaboration in research, appealing to those aiming to make impactful contributions to the biomedical sphere.

Science China-Life Sciences, published by SCIENCE PRESS, is a premier academic journal that stands at the forefront of innovative research and discoveries in the fields of life sciences, spanning crucial areas such as agricultural and biological sciences, biochemistry, genetics, molecular biology, and environmental science. With an impressive Q1 ranking in its respective categories—ranked #5 in Agricultural and Biological Sciences, #7 in Environmental Science, and #17 in Biochemistry, Genetics and Molecular Biology—this journal is recognized for its rigorous peer-review process and significant impact within the scientific community, as reflected in its high percentiles (97th and 92nd). Maintained as an Open Access publication, it ensures broad dissemination and accessibility of research findings, fostering collaboration and knowledge sharing among researchers, professionals, and students alike. Given its position in the research landscape and its commitment to high-quality scholarship, Science China-Life Sciences plays a vital role in advancing life sciences research, supporting scientists in addressing global challenges through innovative biological solutions.

Gazi Medical Journal, an esteemed publication by GALENOS PUBL HOUSE, is a prominent platform in the field of medicine, dedicated to the dissemination of innovative research and critical reviews in diverse medical disciplines. Established in 1992 and transitioning to an Open Access model in 2005, this journal aims to promote unrestricted access to valuable medical knowledge, enhancing the reach and impact of research contributions. With a growing presence in the academic community, it currently holds a Q4 quartile ranking in the category of Medicine (miscellaneous) for 2023, and it ranks at #528 out of 636 in the realm of General Medicine on Scopus, representing the 16th percentile. The journal covers a wide array of topics, making it a vital resource for researchers, healthcare professionals, and students eager to stay informed about the latest medical advancements and practices. Located in the heart of Istanbul, Turkey, Gazi Medical Journal welcomes submissions that inspire thought, spark innovation, and contribute to the ongoing discourse in the medical field.

Biomolecules and Biomedicine is a pioneering open-access journal dedicated to advancing the fields of molecular biology and biomedical sciences, published by the Association of Basic Medical Science Federation Bosnia & Herzegovina in Sarajevo. With the ISSN 2831-0896 and the E-ISSN 2831-090X, this journal aims to facilitate the dissemination of high-quality research from 2023 onwards, inviting submissions that provide innovative insights and findings across various facets of medicine and biological sciences. Positioned within the General Medicine and Biochemistry, Genetics and Molecular Biology categories, it currently holds rankings of 332 out of 636 and 173 out of 221 respectively, highlighting its emerging influence in these fields. As an open-access journal, it ensures that all published research is freely accessible to a global audience, fostering collaboration and knowledge exchange among researchers, professionals, and students alike. With a commitment to enhancing scientific discourse and promoting cutting-edge research, Biomolecules and Biomedicine is poised to become a vital resource for those dedicated to unraveling the complexities of biomolecules and their roles in health and disease.

Cell Reports Medicine, published by Cell Press, represents a pivotal advancement in the open access landscape of biomedical research since its inception in 2020. With a dedicated focus on the intersection of medicine, biochemistry, genetics, and molecular biology, this journal has quickly established itself as a key resource, earning a remarkable Q1 ranking in these fields. Based in the United States, Cell Reports Medicine boasts impressive metrics, ranking #25 out of 636 in General Medicine and #18 out of 221 in Biochemistry, underscoring its influence and reach within the scientific community, with a notable 96th and 92nd percentile respectively. As a fully open access journal, it fosters global dissemination of knowledge, ensuring that groundbreaking research is readily available to researchers, professionals, and students alike. The journal not only promotes high-quality research but also aims to bridge the gap between molecular discoveries and clinical applications, making it an essential addition to any academic library or researcher's toolkit.

Acta Naturae is a peer-reviewed scientific journal published by the Russian Federation Agency for Science & Innovation, focusing on the dynamic fields of Biochemistry, Biotechnology, Molecular Biology, and Molecular Medicine. Launched in 2013, the journal has established a solid reputation in the academic community, with its articles contributing to essential advancements and discussions within these disciplines. By 2023, it has achieved notable rankings—including Q2 status in Biotechnology and Q3 in Biochemistry, Molecular Biology, and Molecular Medicine—indicating its growing influence and relevance in the scientific literature. While currently operating under a non-open access model, Acta Naturae invites researchers, professionals, and students to engage with its comprehensive research reports and reviews that span the breadth of molecular life sciences. With the aim of facilitating scientific dialogue and innovation, this journal serves as a key resource for those seeking to stay at the forefront of molecular research.

The Annual Review of Medicine is a prestigious academic journal published by Annual Reviews that serves as a key resource for researchers, healthcare professionals, and students engaged in the fields of medicine and biochemistry. With its ISSN 0066-4219 and E-ISSN 1545-326X, this journal has been providing comprehensive reviews that cover major developments and trends in medical research since its inception in 1950. Impactful in its category, the Annual Review of Medicine ranks in the Q1 quartile for both Medicine (miscellaneous) and Biochemistry, Genetics and Molecular Biology (miscellaneous), establishing itself within the top percentiles of academic rigor and relevance, exemplified by its impressive Scopus rankings: Rank #12/636 and Rank #6/221 respectively. Although the journal is not open access, it remains an essential resource for contributing valuable insights into evolving medical disciplines, driving evidence-based practice, and fostering innovation among healthcare researchers. The Annual Review of Medicine is instrumental in shaping the future of medicine by synthesizing the most critical findings and fostering an informed understanding of diverse medical challenges.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, published by Elsevier, is a pivotal journal in the fields of Molecular Biology and Molecular Medicine, recognized for its high impact factor and robust ranking within Scopus categories, holding prestigious quartiles in Q1 for both disciplines as of 2023. With ISSN 0925-4439 and E-ISSN 1879-260X, this journal fosters cutting-edge research from 1990 to 2025, addressing the critical molecular mechanisms underlying human diseases. Its wide-ranging scope includes original research articles, reviews, and advanced theoretical insights, serving as an essential resource for researchers, clinicians, and students alike. The journal is based in the Netherlands, at RADARWEG 29, 1043 NX AMSTERDAM, and while it does not currently offer an open-access option, it continues to maintain a strong presence in the scientific community, enhancing our understanding of molecular processes in health and disease.

Advances in Medical Sciences is a peer-reviewed journal published by Elsevier Urban & Partner Sp. z o.o., dedicated to fostering advancements in the field of medicine and healthcare. Established in 2006, this esteemed journal has become a vital resource for researchers, professionals, and students alike, ranking in the Q2 category for Medicine (Miscellaneous) in 2023 and achieving an impressive 84th percentile in the Scopus rankings for General Medicine, placing it at 99 out of 636 journals. With a focus on publishing high-quality research and comprehensive reviews, this journal serves as a platform for disseminating innovative findings that push the boundaries of medical science. Although open access options are not currently available, the journal's rigorous standards ensure that every published article contributes significantly to the global medical community and promotes the understanding of contemporary medical challenges. Located in Wroclaw, Poland, the journal continues to engage a wide readership, driving forward the dialogue in various facets of medical research.

Journal of Biomedical Research, published by Nanjing Medical University in China, is a prominent platform for groundbreaking discoveries in the fields of Biochemistry, Genetics, and Molecular Biology, as well as Medicine. With an ISSN of 1674-8301 and an E-ISSN of 1876-4819, the journal offers a vital opportunity for researchers, professionals, and students to disseminate insightful research findings. Although not currently available as an open access journal, its inclusion in the second quartile of both Biochemistry and Medicine categories underscores its growing influence and commitment to high-quality scholarship, as evidenced by its historical compliance with Scopus rankings prior to 2009. By fostering an interdisciplinary approach, the Journal of Biomedical Research aims to bridge gaps in current biomedical understanding and encourages innovative research that can lead to significant contributions in improving health outcomes. Its editorial policies guarantee rigorous peer review, making it a trusted source of knowledge in the biomedical community.